CCL4 and type 2 diabetes mellitus: More importantly, direct blockade of CCL4 could reverse pancreatic islet cell damage and/or systemic insulin resistance to stabilize the blood sugar levels in both the type 1 and type 2 diabetes models and in the metabolic syndrome animal model.